市場調查報告書
商品編碼
1452632
北美醫療快遞市場預測至 2030 年 - 區域分析 - 按產品類型、目的地、服務和最終用戶North America Medical Courier Market Forecast to 2030 - Regional Analysis - By Product Type, Destination, Service, and End Users |
2022年北美醫療快遞市場價值為22.7026億美元,預計到2030年將達到34.4137億美元;預計 2022 年至 2030 年CAGR為 5.3%。
慢性病盛行率上升推動北美醫療快遞市場
根據 IDF 糖尿病地圖集第 10 版,到 2021 年,十分之一的成年人,即 5.37 億人患有糖尿病(20-79 歲)。到2030年和2045年,這一數字預計將分別增加至6.43億和7.83億。此外,2021 年,糖尿病導致 670 萬人死亡,即每五秒鐘就有一人死亡。此外,腎臟疾病是全球主要的公共衛生問題。慢性腎臟病 (CKD) 和急性腎損傷 (AKI) 都會對健康造成嚴重的負面後果、巨額醫療費用和低生活品質。每年,數百萬成年人因慢性腎臟病 (CKD) 相關併發症而早逝,佔所有成年人死亡人數的 8-10%。此外,根據全球疾病負擔合作網路《2019 年全球疾病負擔研究》,全球每年有 4,100 萬人因非傳染性疾病 (NCD) 死亡,佔總死亡人數的 74%。每年有 1700 萬人在 70 歲前死於非傳染性疾病;低收入和中等收入國家佔這些過早死亡的 86%。 77% 的非傳染性疾病相關死亡發生在低收入和中等收入國家。大多數非傳染性疾病死亡(每年1,790 萬人)是由心血管疾病引起的,其次是癌症(930 萬人)、慢性呼吸道疾病(410 萬人)和糖尿病(200 萬人,包括糖尿病引起的腎臟疾病死亡) )。這四類疾病導致 80% 以上的早期非傳染性疾病死亡。吸煙、空氣污染、不良飲食、有害飲酒和缺乏運動會增加死於非傳染性疾病的風險。
因此,全球糖尿病、慢性腎臟病、非傳染性疾病等慢性病病例的增加同時推動了對醫療用品的需求,並對醫療快遞市場的成長產生積極影響。
北美醫療快遞市場概況
北美醫療快遞市場分為美國、加拿大和墨西哥。 2022年,美國在該地區佔據最大市場佔有率,預計在預測期內將繼續保持主導地位。北美醫療快遞市場的預期成長歸因於腎臟、肝臟和心臟等器官衰竭病例數量的增加,導致器官移植手術數量的增加。器官衰竭病例的增加可能與心臟、腎臟和肝臟相關慢性疾病盛行率的激增有關,這刺激了器官移植的需求。根據器官採購和移植網路的數據,2022 年美國進行了超過 42,800 例器官移植,年成長率約為 3.7%。根據加拿大健康資訊研究所 (CIHI) 的數據,2021 年加拿大進行了約 2,750 例器官移植。美國國立衛生研究院 (NIH) 公佈的數據表明,約 8,500 例移植手術,包括角膜、腎臟、肝臟和2019年3 月至2021 年2 月在墨西哥進行了心臟移植手術。在器官移植過程中,可能需要將器官從一家醫院轉移到另一家醫院。醫療快遞企業提供在適當儲存條件下按時運輸這些器官的服務。醫療快遞服務提供者採用重要的病患照護程序,並確保記錄、報告、醫療用品和實驗室用品的及時有效的運輸。根據美國勞工統計局的數據,2022年美國醫療行業將有約18,000名員工,約佔快遞行業總就業人數的4.5%。由於樣品需求不斷成長,醫療快遞行業的就業人數不斷增加整體治療藥物正在推動市場的成長。此外,在預測期內,醫療保健設施的持續技術進步可能有利於北美醫療快遞市場。 2020 年,UPS Flight Forward 和 CVS 合作,從 CVS 藥房向佛羅裡達州 The Villages 運送處方藥,該社區是美國最大的退休人員社區,擁有超過 135,000 名居民。
北美醫療快遞市場收入及 2030 年預測(百萬美元)
北美醫療快遞市場細分
北美醫療快遞市場根據產品類型、目的地、服務、最終用戶和國家進行細分。
根據產品類型,北美醫療快遞市場分為醫療用品和設備、血液和器官、實驗室標本、醫療筆記等。 2022年,醫療用品和設備領域佔最大佔有率。
按目的地分類,北美醫療快遞市場分為國內和國際。 2022 年,國內市場佔更大佔有率。
依服務分類,北美醫療快遞市場分為標準服務及加急及按需服務。 2022 年,標準服務和加急服務將佔據更大佔有率。
就最終用戶而言,北美醫療快遞市場分為醫院和診所、診斷實驗室、血液和組織庫、藥房、家庭支援、製藥和生物技術公司等。 2022 年,醫院和診所部門佔最大佔有率。
根據國家/地區,北美醫療快遞市場分為美國、加拿大和墨西哥。 2022年,美國在北美醫療快遞市場佔據主導地位。
德國郵政股份公司、聯邦快遞、MNX 全球物流公司、聯合包裹服務公司和 Zipline 國際公司是北美醫療快遞市場上的一些領先公司。
The North America medical courier market was valued at US$ 2,270.26 million in 2022 and is expected to reach US$ 3,441.37 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.
Rising Prevalence of Chronic Diseases Fuels the North America Medical Courier Market
A per the IDF Diabetes Atlas 10th edition, in 2021, One in ten adults, or 537 million, have diabetes (20-79 years old). By 2030 and 2045, this number is expected to increase to 643 million and 783 million, respectively. Further, in 2021, diabetes caused 6.7 million fatalities, or one every five seconds. Furthermore, kidney disease is a major global public health concern. Both chronic kidney disease (CKD) and acute kidney injury (AKI) are associated with significant negative health consequences, substantial medical expenses, and a low quality of life. Every year, millions of adults die early from complications associated with chronic kidney diseases (CKD), accounting for 8-10% of all adult deaths. Also, according to Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2019, noncommunicable diseases (NCDs) account for 41 million annual deaths worldwide, or 74% of all fatalities. 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. 77% of NCD-related deaths occur in low- and middle-income nations. The majority of NCD deaths-17.9 million annually-are caused by cardiovascular illnesses, which are followed in death by cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths from renal disease induced by diabetes). These four categories of diseases cause more than 80% of all early NCD fatalities. Smoking, air pollution, poor diets, hazardous alcohol use, and physical inactivity increase the chance of dying from an NCD.
Thus, the increasing cases of chronic diseases such as diabetes, CKD, NCDs worldwide is simultaneously propelling the demand for medical supplies and positively influencing the medical courier market growth.
North America Medical Courier Market Overview
The North America medical courier market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The projected growth of the North America medical courier market in North America is attributed to the increasing number of organ transplant surgeries owing to a rise in the number of organ failure cases such as kidney, liver, and heart. The rise in organ failure cases can be associated with a surge in the prevalence of chronic diseases related to the heart, kidney, and liver, which fuels the demand for organ transplants. According to the Organ Procurement & Transplantation Network, more than 42,800 organ transplants were performed in the US in 2022, reporting an annual increase of ~3.7%. According to the Canadian Institute of Health Information (CIHI), ~2,750 organ transplantations were carried out in Canada in 2021. Data published by the National Institutes of Health (NIH) states that ~8,500 transplantation procedures, including cornea, kidney, liver, and heart, were performed in Mexico from March 2019 to February 2021. During organ transplants, there may be a necessity to transfer the organ from one hospital to another. Medical courier businesses provide services to transport these organs on time in proper storage conditions. Medical courier service providers adopt vital patient care procedures, and ensure the prompt and efficient transportation of records, reports, medical supplies, and laboratory supplies. According to the US Bureau of Labor Statistics, ~18,000 employees-approximately 4.5% of the total courier industry employment-were employed in the medical industry in the US in 2022. The increasing employment in the medical courier industry due to the growing demand for samples and medicines for overall treatment is fueling the growth of the market. Further, the ongoing technological advancements in healthcare facilities are likely to benefit the North America medical courier market in North America during the forecast period. In 2020, UPS Flight Forward and CVS partnered to deliver prescription medicines from CVS pharmacy stores to The Villages, Florida, the largest retired people's community in the US, which is home to more than 135,000 residents.
North America Medical Courier Market Revenue and Forecast to 2030 (US$ Million)
North America Medical Courier Market Segmentation
The North America medical courier market is segmented based on product type, destination, service, end users, and country.
Based on product type, the North America medical courier market is segmented into medical supplies and equipment, blood and organs, lab specimens, medical notes, and others. The medical supplies and equipment segment held the largest share in 2022.
By destination, the North America medical courier market is bifurcated into domestic and international. The domestic segment held a larger share in 2022.
By service, the North America medical courier market is bifurcated into standard service and rush and on-demand services. The standard service and rush segment held a larger share in 2022.
In terms of end users, the North America medical courier market is categorized into hospital and clinics, diagnostic labs, blood and tissue banks, pharmacy, in home support, pharmaceutical and biotechnology companies, and others. The hospital and clinics segment held the largest share in 2022.
Based on country, the North America medical courier market is segmented into the US, Canada, and Mexico. The US dominated the North America medical courier market in 2022.
Deutsche Post AG, FedEx Corp, MNX Global Logistics Corp, United Parcel Service Inc, and Zipline International Inc are some of the leading companies operating in the North America medical courier market.